{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:54:15Z","timestamp":1762520055636,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jinf.2010.04.004","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T04:48:59Z","timestamp":1271652539000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults"],"prefix":"10.1016","volume":"61","author":[{"given":"James","family":"Molton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Chaytor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Maple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2010.04.004_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QCO.0b013e328334fec4","article-title":"Immunization for HIV-positive individuals","volume":"23","author":"Geretti","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib2","first-page":"795","article-title":"British HIV Association guidelines for immunization of HIV-infected adults 2008","volume":"9","author":"Geretti","year":"2008","journal-title":"HIV\u00a0Med"},{"key":"10.1016\/j.jinf.2010.04.004_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/526789","article-title":"Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease","volume":"197","author":"Moir","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/598193","article-title":"Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients","volume":"48","author":"Evison","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jcp.55.2.154","article-title":"Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy","volume":"55","author":"Kudesia","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jinf.2010.04.004_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0950268801005234","article-title":"The seroepidemiology of measles in Western Europe","volume":"126","author":"de Melker","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2010.04.004_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S0950268803008768","article-title":"Sero-epidemiology of mumps in western Europe","volume":"131","author":"Nardone","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2010.04.004_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268899004574","article-title":"The seroepidemiology of rubella in western Europe","volume":"125","author":"Pebody","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2010.04.004_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S0950268898001745","article-title":"The prevalence of hepatitis B infection in adults in England and Wales","volume":"122","author":"Gay","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2010.04.004_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.04.004_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1258\/095646207782193902","article-title":"Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy","volume":"18","author":"O\u2019Riordan","year":"2007","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jinf.2010.04.004_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bmj.38170.691956.AE","article-title":"Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study","volume":"329","author":"MacMahon","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2010.04.004_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-0528.2004.00320.x","article-title":"Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland","volume":"112","author":"Alanen","year":"2005","journal-title":"BJOG"},{"article-title":"Immunisation against infectious disease","year":"2006","author":"Salisbury","key":"10.1016\/j.jinf.2010.04.004_bib14"},{"key":"10.1016\/j.jinf.2010.04.004_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2010.04.004_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/CVI.13.2.214-218.2006","article-title":"Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay","volume":"13","author":"Maple","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2010.04.004_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jviromet.2008.12.007","article-title":"Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection","volume":"157","author":"Chris Maple","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jinf.2010.04.004_bib18","doi-asserted-by":"crossref","first-page":"b533","DOI":"10.1136\/bmj.b533","article-title":"Measles cases in England and Wales rise sharply in 2008","volume":"338","author":"Eaton","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2010.04.004_bib19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination","volume":"4","author":"Moss","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2010.04.004_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/515679","article-title":"The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California","volume":"178","author":"Kemper","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib21","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.04.004_bib22","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/379900","article-title":"Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion","volume":"188","author":"Lederman","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.1990.01670320057007","article-title":"Varicella in patients infected with the human immunodeficiency virus","volume":"126","author":"Perronne","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jinf.2010.04.004_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/aje\/kwh107","article-title":"A\u00a0population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales","volume":"159","author":"Morris-Cunnington","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jinf.2010.04.004_bib25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/374562","article-title":"Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial","volume":"187","author":"Kemper","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vaccine.2005.07.102","article-title":"Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis","volume":"24","author":"Shire","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2010.04.004_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200001070-00002","article-title":"Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen","volume":"14","author":"Valdez","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.04.004_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis A vaccine in HIV-positive patients","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jinf.2010.04.004_bib29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM198703053161015","article-title":"Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV","volume":"316","author":"Biggar","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.04.004_bib30","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2010.04.004_bib31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/420740","article-title":"Hepatitis A and B vaccination practices for ambulatory patients infected with HIV","volume":"38","author":"Tedaldi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.04.004_bib33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.510290447","article-title":"Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men","volume":"29","author":"Colin","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jinf.2010.04.004_bib34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1086\/599110","article-title":"Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis","volume":"48","author":"Nikolopoulos","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310001246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310001246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:14:11Z","timestamp":1759007651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445310001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0163445310001246"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2010.04.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2010.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}